14/04/2021

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

14/04/2021 No Comments

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Open Letter by U.S. Doctors: JAMA Anti-Ivermectin Study Is Misleading and Fatally Flawed

14/04/2021 No Comments

The severe weaknesses of this study make it uninformative about whether ivermectin is beneficial in early COVID-19 treatment. Yet, the authors misleadingly conclude that their findings “do not support the use of ivermectin for treatment of mild COVID-19”, as if they had enough quality data to make that case, which they do not.

These Brave Doctors are Upholding Their Hippocratic Oath & Putting Patients—Not Profits—First With Ivermectin

14/04/2021 No Comments

FLCCC Weekly Update: “Big Science vs Little Science”—April 14, 2021 Drs. Jose Morgenstern and Jose Redondo of the Dominican Republic share their new ivermectin study and tell the story of how they discovered the efficacy of ivermectin in April, 2020.

The Palmer Foundation

Day: April 14, 2021

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Open Letter by U.S. Doctors: JAMA Anti-Ivermectin Study Is Misleading and Fatally Flawed

These Brave Doctors are Upholding Their Hippocratic Oath & Putting Patients—Not Profits—First With Ivermectin

Copyright 2020 © The Palmer Foundation